PetMed Express, Inc. (NASDAQ:PETS) CEO Menderes Akdag sold 30,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 11th. The shares were sold at an average price of $51.00, for a total transaction of $1,530,000.00. Following the completion of the sale, the chief executive officer now owns 490,000 shares of the company’s stock, valued at $24,990,000. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of PetMed Express, Inc. (PETS) opened at $52.94 on Tuesday. PetMed Express, Inc. has a one year low of $19.21 and a one year high of $53.32. The company has a market cap of $1,090.79, a price-to-earnings ratio of 35.53, a PEG ratio of 3.14 and a beta of 1.12.

PetMed Express (NASDAQ:PETS) last posted its quarterly earnings data on Monday, October 23rd. The company reported $0.43 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.30 by $0.13. PetMed Express had a net margin of 11.58% and a return on equity of 31.46%. The business had revenue of $66.70 million during the quarter, compared to the consensus estimate of $63.41 million. During the same period in the previous year, the firm posted $0.24 earnings per share. The business’s revenue for the quarter was up 9.7% compared to the same quarter last year. research analysts expect that PetMed Express, Inc. will post 1.68 EPS for the current fiscal year.

Large investors have recently bought and sold shares of the company. Acrospire Investment Management LLC acquired a new stake in shares of PetMed Express during the second quarter worth $110,000. Pinebridge Investments L.P. lifted its stake in shares of PetMed Express by 1.0% during the second quarter. Pinebridge Investments L.P. now owns 2,704 shares of the company’s stock worth $110,000 after buying an additional 27 shares during the period. Sei Investments Co. lifted its stake in shares of PetMed Express by 50,142.9% during the third quarter. Sei Investments Co. now owns 3,517 shares of the company’s stock worth $117,000 after buying an additional 3,510 shares during the period. Thompson Siegel & Walmsley LLC acquired a new stake in shares of PetMed Express during the third quarter worth $149,000. Finally, Fred Alger Management Inc. acquired a new stake in shares of PetMed Express during the second quarter worth $162,000. Institutional investors and hedge funds own 99.88% of the company’s stock.

PETS has been the subject of several recent analyst reports. Zacks Investment Research downgraded shares of PetMed Express from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 25th. BidaskClub upgraded shares of PetMed Express from a “buy” rating to a “strong-buy” rating in a research note on Saturday, December 9th. Northcoast Research set a $58.00 target price on shares of PetMed Express and gave the company a “buy” rating in a research note on Wednesday, January 3rd. ValuEngine downgraded shares of PetMed Express from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. Finally, Noble Financial restated a “hold” rating on shares of PetMed Express in a research note on Friday, October 27th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $42.80.

WARNING: This story was originally published by Daily Political and is owned by of Daily Political. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://www.dailypolitical.com/2018/01/16/menderes-akdag-sells-30000-shares-of-petmed-express-inc-pets-stock.html.

About PetMed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Insider Buying and Selling by Quarter for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.